These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12656811)

  • 1. Botulinum toxin type B.
    Sadick NS
    Dermatol Surg; 2003 Apr; 29(4):348-50; discussion 350-1. PubMed ID: 12656811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides.
    Sadick NS; Herman AR
    Dermatol Surg; 2003 Apr; 29(4):340-7. PubMed ID: 12656810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.
    Aoki KR; Guyer B
    Eur J Neurol; 2001 Nov; 8 Suppl 5():21-9. PubMed ID: 11851731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of botulinum toxin types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides.
    Matarasso SL
    Dermatol Surg; 2003 Jan; 29(1):7-13; discussion 13. PubMed ID: 12534505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of botulinum toxins: past, present, and future.
    Cartee TV; Monheit GD
    Clin Plast Surg; 2011 Jul; 38(3):409-26, vi. PubMed ID: 21824539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A and B raise blood flow and increase survival of critically ischemic skin flaps.
    Schweizer DF; Schweizer R; Zhang S; Kamat P; Contaldo C; Rieben R; Eberli D; Giovanoli P; Erni D; Plock JA
    J Surg Res; 2013 Oct; 184(2):1205-13. PubMed ID: 23651811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and immunology of botulinum toxin serotypes.
    Aoki KR
    J Neurol; 2001 Apr; 248 Suppl 1():3-10. PubMed ID: 11357237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type B (Myobloc): pharmacology and biochemistry.
    Callaway JE
    Clin Dermatol; 2004; 22(1):23-8. PubMed ID: 15158541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin B: the new option in cosmetic injection.
    Spencer JM
    J Drugs Dermatol; 2002 Jul; 1(1):17-22. PubMed ID: 12847750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin type B--a rapid wrinkle reducer.
    Jacob CI
    Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.
    Flynn TC; Clark RE
    Dermatol Surg; 2003 May; 29(5):519-22; discussion 522. PubMed ID: 12752521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of botulinum toxin.
    Dressler D
    Curr Opin Microbiol; 2012 Jun; 15(3):325-36. PubMed ID: 22770659
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Dis Mon; 2002 May; 48(5):367-83. PubMed ID: 12195266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin for the treatment of major depressive disorder].
    Hawlik AE; Freudenmann RW; Pinkhardt EH; Schönfeldt-Lecuona CJ; Gahr M
    Fortschr Neurol Psychiatr; 2014 Feb; 82(2):93-9. PubMed ID: 24519192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A.
    Houser MK; Sheean GL; Lees AJ
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):577-80. PubMed ID: 9598669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.